— Know what they know.
Not Investment Advice

000078.SZ SHZ

Shenzhen Neptunus Bioengineering Co., Ltd.
1W: -22.5% 1M: -54.4% 3M: -50.3% YTD: -53.9% 1Y: -28.9% 3Y: -50.3% 5Y: -55.1%
¥1.63 ($0.24)
-0.09 (-5.23%)
 
Weekly Expected Move ±9.0%
¥2 ¥2 ¥2 ¥2 ¥2
SHZ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 31 · ¥4.3B mcap · 1.40B float · 8.22% daily turnover
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥4.3B ($631.3M)
52W Range1.63-5.7
Volume46,478,500
Avg Volume115,477,746
Beta0.73
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOFeng Zhang
Employees9,093
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1998-12-18
Wang Yinhe Technology Building
Shenzhen 518057
CN
86 755 2698 0336
About Shenzhen Neptunus Bioengineering Co., Ltd.

Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers drugs in the fields of anti-tumor, cardio-cerebrovascular, marine drugs, and other fields. The company was founded in 1989 and is based in Shenzhen, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms